BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7480013)

  • 1. Nitric oxide synthase antagonism potentiates pressure-flow autoregulation in the superior mesenteric artery.
    Macedo MP; Lautt WW
    Proc West Pharmacol Soc; 1995; 38():33-4. PubMed ID: 7480013
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitro.
    Zanchi A; Aubert JF; Brunner HR; Waeber B
    Cardiovasc Res; 1995 Jul; 30(1):122-9. PubMed ID: 7553714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide suppression of norepinephrine release from nerves in the superior mesenteric artery.
    Macedo MP; Lautt WW
    Proc West Pharmacol Soc; 1994; 37():103-4. PubMed ID: 7984633
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoregulation of renal and splanchnic blood flow following infra-renal aortic clamping is mediated by nitric oxide and vasodilator prostanoids.
    Myers SI; Turnage RH; Hernandez R; Castenada A; Valentine RJ
    J Cardiovasc Surg (Torino); 1996 Apr; 37(2):97-103. PubMed ID: 8675533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans.
    White RP; Vallance P; Markus HS
    Clin Sci (Lond); 2000 Dec; 99(6):555-60. PubMed ID: 11099400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shear-induced release of nitric oxide antagonizes adenosine effects on intestine metabolism.
    Han C; Lautt WW
    Proc West Pharmacol Soc; 1998; 41():33-4. PubMed ID: 9836232
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
    Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
    Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between nitric oxide and renal myogenic autoregulation in normotensive and hypertensive rats.
    Wang X; Cupples WA
    Can J Physiol Pharmacol; 2001 Mar; 79(3):238-45. PubMed ID: 11294600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in cochlear blood flow with infusion of nitric oxide synthase inhibitor and its recovery with L-arginine infusion: comparison with abdominal blood flow and auricular blood flow.
    Hoshijima H; Makimoto K
    Acta Otolaryngol; 2002 Dec; 122(8):808-15. PubMed ID: 12542197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrimental effects of nitric oxide on mesenteric circulation during endotoxaemia and its reversal by aminoguanidine.
    Yorganci K; Sayek I; Ismailoglu UB; Sahin-Erdemli I
    Eur J Surg; 2000 Nov; 166(11):888-93. PubMed ID: 11097157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism prevents the development of hypertension during chronic cold stress.
    Westfall TC; Yang CL; Chen X; Naes L; Vickery L; Macarthur H; Han S
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):171-7. PubMed ID: 16176449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
    Bexis S; Vandeputte C; McCormick PA; Docherty JR
    Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nitric oxide donor and nitric oxide synthase inhibitor on the resistance, exchange and capacitance functions of the canine intestinal vasculature.
    Hsieh NK; Chang HR; Hu CT; Chen HI
    Vascul Pharmacol; 2008; 48(2-3):122-8. PubMed ID: 18295548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nitric oxide synthase inhibitor on optic nerve head circulation in conscious rabbits.
    Sugiyama T; Oku H; Ikari S; Ikeda T
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1149-52. PubMed ID: 10752953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
    Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulatory capacity in the superior mesenteric artery is attenuated by nitric oxide.
    Macedo MP; Lautt WW
    Am J Physiol; 1996 Sep; 271(3 Pt 1):G400-4. PubMed ID: 8843761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats.
    Painsipp E; Shahbazian A; Holzer P
    Br J Pharmacol; 2009 Nov; 158(5):1210-26. PubMed ID: 19785647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.